Nuestros blogs explican las afecciones de salud y la investigación clínica de una manera fácil de entender, para que los lectores se sientan más informados.
Fertility Drugs Do Not Increase Breast Cancer Risk
Women who took clomiphene citrate (brand name Clomid) or gonadotropins as a part of fertility treatment did not experience an increased risk for breast cancer over 30 years of follow-up, compared with women who were not treated with these medications, according...
Ketamine Can Treat Severe Depression
The first UK study of the use of ketamine intravenous infusions in people with treatment-resistant depression has been carried out in an NHS clinic by researchers at Oxford Health NHS Foundation Trust and the University of Oxford. “Ketamine is a promising...
Experimental Cancer Drug Reverses Schizophrenia in Mice
Johns Hopkins researchers say that an experimental anticancer compound appears to have reversed behaviors associated with schizophrenia and restored some lost brain cell function in adolescent mice with a rodent version of the devastating mental illness. The drug is one of...
Breakthrough in Stem Cell Manufacturing Technology
Scientists at The University of Nottingham have developed a new substance that could simplify the manufacture of cell therapy in the world of regenerative medicine. Cell therapy is an exciting and rapidly developing area of medicine in which stem cells have...
Study Shows Marital Status Affects Risk of Heart Disease
Marriage is criticized for many things—justly and unjustly—but not heart disease, according to findings of a recent study conducted by researchers at NYU Langone Medical Center. Analysis of surveys of more than 3.5 million American men and women, administered at some...
Cancer cells explode with new treatment
Researchers at Karolinska Institutet in Sweden have discovered that a substance called Vacquinol-1 makes cells from glioblastoma, the most aggressive type of brain tumor, literally explode. When mice were given the substance, which can be given in tablet form, tumor growth...
FDA approves Impavido to treat tropical disease leishmaniasis
The U.S. Food and Drug Administration today approved Impavido (miltefosine) to treat a tropical disease called leishmaniasis. Leishmaniasis treatment is essential for those affected by this parasitic infection, primarily transmitted by sand fly bites. The disease occurs primarily in people who...